Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMYMP) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Bristol Myers Squibb (BMYMP) over the last 17 years, with Q4 2025 value amounting to $977.0 million.

  • Bristol Myers Squibb's Depreciation & Amortization (CF) fell 4803.19% to $977.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $4.0 billion, marking a year-over-year decrease of 5821.88%. This contributed to the annual value of $4.0 billion for FY2025, which is 5821.88% down from last year.
  • As of Q4 2025, Bristol Myers Squibb's Depreciation & Amortization (CF) stood at $977.0 million, which was down 4803.19% from $1.0 billion recorded in Q3 2025.
  • In the past 5 years, Bristol Myers Squibb's Depreciation & Amortization (CF) ranged from a high of $2.7 billion in Q3 2021 and a low of $977.0 million during Q4 2025
  • Over the past 5 years, Bristol Myers Squibb's median Depreciation & Amortization (CF) value was $2.5 billion (recorded in 2022), while the average stood at $2.2 billion.
  • In the last 5 years, Bristol Myers Squibb's Depreciation & Amortization (CF) skyrocketed by 771.09% in 2021 and then tumbled by 6105.55% in 2025.
  • Over the past 5 years, Bristol Myers Squibb's Depreciation & Amortization (CF) (Quarter) stood at $2.6 billion in 2021, then dropped by 2.25% to $2.5 billion in 2022, then dropped by 2.26% to $2.5 billion in 2023, then dropped by 23.7% to $1.9 billion in 2024, then plummeted by 48.03% to $977.0 million in 2025.
  • Its last three reported values are $977.0 million in Q4 2025, $1.0 billion for Q3 2025, and $1.0 billion during Q2 2025.